These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22537360)

  • 1. A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism.
    Fung LK; Chahal L; Libove RA; Bivas R; Hardan AY
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):245-8. PubMed ID: 22537360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
    Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
    Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.
    Stigler KA; Diener JT; Kohn AE; Li L; Erickson CA; Posey DJ; McDougle CJ
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):265-74. PubMed ID: 19519261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
    Aman MG; Kasper W; Manos G; Mathew S; Marcus R; Owen R; Mankoski R
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):415-22. PubMed ID: 20973712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.
    Barzman DH; DelBello MP; Kowatch RA; Gernert B; Fleck DE; Pathak S; Rappaport K; Delgado SV; Campbell P; Strakowski SM
    J Child Adolesc Psychopharmacol; 2004; 14(4):593-600. PubMed ID: 15662152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.
    Masi G; Cosenza A; Millepiedi S; Muratori F; Pari C; Salvadori F
    CNS Drugs; 2009; 23(6):511-21. PubMed ID: 19480469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole for autism spectrum disorders (ASD).
    Ching H; Pringsheim T
    Cochrane Database Syst Rev; 2012 May; (5):CD009043. PubMed ID: 22592735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder.
    Huang SC; Tsai SJ; Yang HJ
    Chang Gung Med J; 2010; 33(2):211-5. PubMed ID: 20438675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole in the treatment of bipolar disorder in children and adolescents.
    Durkin JP
    J Child Adolesc Psychopharmacol; 2004; 14(4):505-6. PubMed ID: 15662141
    [No Abstract]   [Full Text] [Related]  

  • 10. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.
    Budman C; Coffey BJ; Shechter R; Schrock M; Wieland N; Spirgel A; Simon E
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):509-15. PubMed ID: 18928415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.
    Ho JG; Caldwell RL; McDougle CJ; Orsagh-Yentis DK; Erickson CA; Posey DJ; Stigler KA
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):277-83. PubMed ID: 22849533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.
    Ercan ES; Uysal T; Ercan E; Akyol Ardic U
    Pharmacopsychiatry; 2012 Jan; 45(1):13-9. PubMed ID: 21993869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole for maladaptive behavior in pervasive developmental disorders.
    Stigler KA; Posey DJ; McDougle CJ
    J Child Adolesc Psychopharmacol; 2004; 14(3):455-63. PubMed ID: 15650503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of catatonia with aripiprazole in an adolescent with psychosis.
    Strawn JR; Delgado SV
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):733-5. PubMed ID: 17979595
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole in children and adolescents: clinical experience.
    Rugino TA; Janvier YM
    J Child Neurol; 2005 Jul; 20(7):603-10. PubMed ID: 16159529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders.
    Maloney A; Mick EO; Frazier J
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):357-9. PubMed ID: 24828130
    [No Abstract]   [Full Text] [Related]  

  • 19. A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
    Ghanizadeh A; Sahraeizadeh A; Berk M
    Child Psychiatry Hum Dev; 2014; 45(2):185-92. PubMed ID: 23801256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.
    Varni JW; Handen BL; Corey-Lisle PK; Guo Z; Manos G; Ammerman DK; Marcus RN; Owen R; McQuade RD; Carson WH; Mathew S; Mankoski R
    Clin Ther; 2012 Apr; 34(4):980-92. PubMed ID: 22444782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.